IP Library › Assignment 059370/0442
Patent Assignment
Reel/Frame 059370/0442

Change of Name

Recorded: 2022-03-16 Pages: 4
Assignor
BOSTON BIOMEDICAL, INC.
Executed: 2020-07-01
Assignee
SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property (1)
Axl Kinase Inhibitors and Use of the Same
Application: 17/092,521 →
Publication: US 2021/0205304
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 16, 2022
From: SIDDIQUI-JAIN, ADAM; WARNER, STEVEN L.; FLYNN, PAUL; BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 059284/0161 →
Assignment of Assignor's Interest Mar 16, 2022
From: TOMIMATSU, NOZOMI; FUJIMURA, KEN; UMEHARA, HIROKI; NONOYAMA, AKIHITO
To: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
Reel/Frame 059284/0406 →
Assignment of Assignor's Interest Mar 16, 2022
From: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 059284/0552 →
Merger Mar 16, 2022
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 059284/0663 →
Change of Name Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059809/0557 →